Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obes...
Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data
About this item
Full title
Author / Creator
Poynard, Thierry , Lassailly, Guillaume , Diaz, Emmanuel , Clement, Karine , Caïazzo, Robert , Tordjman, Joan , Munteanu, Mona , Perazzo, Hugo , Demol, Bernard , Callafe, Robert , Pattou, François , Charlotte, Frederic , Bedossa, Pierre , Mathurin, Philippe , Ratziu, Vlad , for the FLIP consortium and FLIP consortium
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Liver biopsy is considered as the gold standard for assessing non-alcoholic fatty liver disease (NAFLD) histologic lesions in patients with severe obesity. The aim of this study was to perform an overview of 3 studies which assessed the performance of non-invasive markers of fibrosis (FibroTest), steatosis (SteatoTest) and steato-hepatitis (NashTes...
Alternative Titles
Full title
Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1323990607
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1323990607
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0030325
